Annual Drug Patent Expirations for ACULAR+LS
Acular Ls is a drug marketed by Abbvie and is included in one NDA. It is available from three suppliers. There are eight patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for ACULAR LS.
This drug has five patent family members in three countries.
The generic ingredient in ACULAR LS is ketorolac tromethamine. Three suppliers are listed for this compound. Additional details are available on the ketorolac tromethamine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
